Antimicrobial-resistant bacteria in the community setting

Nature Reviews Microbiology

Volumn 4, Issue 1, 2006, Pages 36-45

  Furuya, E Yoko ^a   Lowy, Franklin D ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; ERYTHROMYCIN; MACROLIDE; METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; COMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; BACTERIAL INFECTIONS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DISEASE RESERVOIRS; DRUG RESISTANCE, BACTERIAL; FOOD MICROBIOLOGY; HUMANS; METHICILLIN RESISTANCE; PENICILLIN RESISTANCE; PUBLIC HEALTH; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 31344459549     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1325     Document Type: Review

References (136)

1. Rammelkamp, C. H. & Maxon, T. Resistance of Staphylococcus aureus to the action of penicillin. Proc. Royal Soc. Experim. Biol. Med. 51, 386-389 (1942).
2. Goossens, H., Ferech, M., Vander Stichele, R. & Elseviers, M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 365, 579-587 (2005).
3. Mellon, M., Benbrook, C. & Benbrook, K. Hogging It: Estimates of Antimicrobial Abuse in Livestock (UCS Publications, Cambridge, 2001).
4. Gonzales, R., Steiner, J. F. & Sande, M. A. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278, 901-904 (1997).
5. Nyquist, A. C., Gonzales, R., Steiner, J. F. & Sande, M. A. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 279, 875-857 (1998).
6. Watanabe, T. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27, 87-115 (1963).
7. Brown, D. F. & Reynolds, P. E. Intrinsic resistance to β-lactam antibiotics in Staphylococcus aureus. FEBS Lett. 122, 275-278 (1980).
8. Stokes, H. W. & Hall, R. M. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: Integrons. Mol. Microbiol. 3, 1669-1683 (1989).
9. Griggs, D. J., Gensberg, K. & Piddock, L. J. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob. Agents Chemother. 40, 1009-1013 (1996).
10. Jorgensen, J. H., Weigel, L. M., Ferraro, M. J., Swenson, J. M. & Tenover, F. C. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob. Agents Chemother. 43, 329-334 (1999).
11. Kruse, H., Sorum, H., Tenover, F. C. & Olsvik, O. A transferable multiple drug resistance plasmid from Vibrio cholerae O 1. Microb. Drug Resist. 1, 203-210 (1995).
12. Sadowski, P., Peterson, B. C., Gerding, D. L. & Cleary, P. P. Physical characterization often R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections. Antimicrob. Agents Chemother. 15, 616-624 (1979).
13. Barza, M. & Travers, K. Excess infections due to antimicrobial resistance: The "Attributable Fraction". Clin. Infect. Dis. 34, S126-S130 (2002).
14. Daum, R. S., Gupta, S., Sabbagh, R. & Milewski, W. M. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: Isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166, 1066-1072 (1992).
15. Sieradzki, K. & Tomasz, A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179, 2557-2566 (1997).
16. Smith, T. L. et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N. Engl. J. Med. 340, 493-501 (1999).
17. Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H. & Hiramatsu, K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44, 2276-2285 (2000).
18. Gonzalez-Zorn, B. & Courvalin, P. VanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect. Dis. 3, 67-68 (2003).
19. Martinez, J. L. & Baquero, F. Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15, 647-679 (2002).
20. Russell, A. D., Hammond, S. A. & Morgan, J. R. Bacterial resistance to antiseptics and disinfectants. J. Hosp. Infect. 7, 213-225 (1986).
21. Anwar, H., Strap, J. L., Chen, K. & Costerton, J. W. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob. Agents Chemother. 36, 1208-1214 (1992).
22. Donlan, R. M. Biofilms and device-associated infections. Emerg. Infect. Dis. 7, 277-281 (2001).
23. O'Brien, L. M., Walsh, E. J., Massey, R. C., Peacock, S. J. & Foster, T. J. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: Implications for nasal colonization. Cell. Microbiol. 4, 759-770 (2002).
24. Weidenmaier, C. et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nature Med. 10, 243-245 (2004).
25. Bell, D. C., Montoya, I. D., Atkinson, J. S. & Yang, S. J. Social networks and forecasting the spread of HIV infection. J. Acquir. Immune Defic. Syndr. 31, 218-229 (2002).
26. Klovdahl, A. S. et al. Networks and tuberculosis: An undetected community outbreak involving public places. Soc. Sci. Med. 52, 681-694 (2001).
27. Lowy, F. D. & Miller, M. New methods to investigate infectious disease transmission and pathogenesis - Staphylococcus aureus disease in drug users. Lancet Infect. Dis. 2, 605-612 (2002).
28. Ward, H. et al. A prospective social and molecular investigation of gonococcal transmission. Lancet 356, 1812-1817 (2000).
29. Burman, L. A., Norrby R. & Trollfors, B. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis. Rev. Infect. Dis. 7, 133-142 (1985).
30. Hansman, D. & Bullen, M. M. A resistant pneumococcus. Lancet 290, 264 (1967).
31. Zighelboim, S. & Tomasz, A. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17, 434-442 (1980).
32. Dowson, C. G., Coffey, T. J. & Spratt, B. G. Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to β-lactam antibiotics. Trends Microbiol. 2, 361-366 (1994).
33. Doern, G. V. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. Infect. Dis. 33, S187-S192 (2001).
34. Doern, G. V. & Brown, S. D. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: Data from PROTEKT US 2000-01. J. Infect. 48, 56-65 (2004).
35. Clavo-Sanchez, A. J. et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin. Infect. Dis. 24, 1052-1059 (1997).
36. Pallares, R. et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N. Engl. J. Med. 317, 18-22 (1987).
37. Albrich, W. C., Monnet, D. L. & Harbarth, S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10, 514-517 (2004).
38. Bronzwaer, S. L. et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8, 278-282 (2002).
39. Corso, A., Severina, E. P., Petruk, V. F., Mauriz, Y. R. & Tomasz, A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resist. 4, 325-337 (1998).
40. Soares, S., Kristinsson, K. G., Musser, J. M. & Tomasz, A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168, 158-163 (1993).
41. Duchin, J. S. et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr. Infect. Dis. J. 14, 745-750 (1995).
42. Neto, A. S. et al. Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: Phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae. Microb. Drug Resist. 9, 99-108 (2003).
43. Dudley, S., Ashe, K., Winther, B. & Hendley, J. O. Bacterial pathogens of otitis media and sinusitis: Detection in the nasopharynx with selective agar media. J. Lab. Clin. Med. 138, 338-342 (2001).
44. McCormick, A. W. et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nature Med. 9, 424-430 (2003).
45. McEwen, S. A. & Fedorka-Cray, P. J. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 34, S93-S106 (2002).
46. Levy, S. B., FitzGerald, G. B. & Macone, A. B. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N. Engl. J. Med. 295, 583-588 (1976).
47. Uttley A. H., Collins, C. H., Naidoo, J. & George, R. C. Vancomycin-resistant enterococci. Lancet 1, 57-58 (1988).
48. Aarestrup, F. M. et al. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemother. 40, 1938-1940 (1996).
49. Klare, I., Heier, H., Claus, H., Reissbrodt, R. & Witte, W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125, 165-171 (1995).
50. Bates, J., Jordens, J. & Griffiths, D. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34, 507-514 (1994).
51. van den Bogaard, A. E., Jensen, L. B. & Stobberingh, E. E. Vancomycin-resistant enterococci in turkeys and farmers. N. Engl. J. Med. 337, 1558-1559 (1997).
52. Coque, T., Tomayko, J., Ricke, S., Okhyusen, P. & Murray, B. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob. Agents Chemother. 40, 2605-2609 (1996).
53. Jordens, J. Z., Bates, J. & Griffiths, D. T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34, 515-528 (1994).
54. Klare, I., Heier, H., Claus, H. & Witte, W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol. Lett. 106, 23-29 (1993).
55. Mead, P. S., Slutsker, L., Griffin, P. M. & Tauxe, R. V. Food-related illness and death in the United States reply to Dr Hedberg. Emerg. Infect. Dis. 5, 841-842 (1999).
56. White, D. G. et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N. Engl. J. Med. 345, 1147-1154 (2001).
57. Blaser, M. J. & Newman, L. S. A review of human salmonellosis: I. Infective dose. Rev. Infect. Dis. 4, 1096-1106 (1982).
58. Woodward, D. L., Khakhria, R. & Johnson, W. M. Human salmonellosis associated with exotic pets. J. Clin. Microbiol. 35, 2786-2790 (1997).
59. CDC. Outbreak of multidrug-resistant Salmonella typhimurium associated with rodents purchased at retail pet stores - United States, December 2003-October 2004. MMWR Morb. Mortal. Wkly Rep. 54, 429-433 (2005).
60. Threlfall, E. J. et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: Results of international multi-centre surveillance. Euro Surveill. 8, 41-45 (2003).
61. Casin, I. et al. Multidrug-resistant human and animal Salmonella typhimurium isolates in France belong predominantly to a DT 104 clone with the chromosome- and integron-encoded β-lactamase PSE-1. J. Infect. Dis. 179, 1173-1182 (1999).
62. Ridley, A. & Threlfall, E. J. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb. Drug Resist. 4, 113-118 (1998).
63. Threlfall, E. J., Frost, J. A., Ward, L. R. & Rowe, B. Epidemic in cattle and humans of Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet. Rec. 134, 577 (1994).
64. Hakanen, A., Kotilainen, P., Huovinen, P., Helenius, H. & Siitonen, A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg. Infect. Dis. 7, 996-1003 (2001).
65. Isenbarger, D. W. et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg. Infect. Dis. 8, 175-180 (2002).
66. Molbak, K., Gerner-Smidt, P. & Wegener, H. C. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg. Infect. Dis. 8, 514-515 (2002).
67. Chiu, C. H. et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N. Engl. J. Med. 346, 413-419 (2002).
68. National Antimicrobial Resistance Monitoring System for Enteric Bacteria: Annual Report, 2001 (Centers for Disease Control and Prevention, Atlanta, 2001).
69. Threlfall, E. J., Graham, A., Cheasty T., Ward, L. R. & Rowe, B. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996. J. Clin. Pathol. 50, 1027-1028 (1997).
70. Cody, S. H. et al. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT 104 infections linked to raw-milk cheese in Northern California. JAMA 281, 1805-1810 (1999).
71. Villar, R. G. et al. Investigation of multidrug-resistant Salmonella serotype typhimurium DT 104 infections linked to raw-milk cheese in Washington State. JAMA 281, 1811-1816 (1999).
72. Threlfall, E. J. Antimicrobial drug resistance in Salmonella: Problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev. 26, 141-148 (2002).
73. Piddock, L. J. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol. Rev. 26, 3-16 (2002).
74. Threlfall, E. J., Ward, L. R., Skinner, J. A. & Rowe, B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: A comparison of data for 1994 and 1996. Microb. Drug Resist. 3, 263-266 (1997).
75. Olsen, S. J. et al. A nosocomial outbreak of fluoroquinolone-resistant salmonella infection. N. Engl. J. Med. 344, 1572-1579 (2001).
76. Aarestrup, F. M. et al. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 45, 2054-2059 (2001).
77. Wierup, M. The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb. Drug Resist. 7, 183-190 (2001).
78. Casewell, M. W. & Hill, R. L. The carrier state: Methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 18 (Suppl. A), 1-12 (1986).
79. Noble, W. C., Valkenburg, H. A. & Wolters, C. H. Carriage of Staphylococcus aureus in random samples of a normal population. J. Hyg. (Lond.) 65, 567-573 (1967).
80. Wenzel, R. P. & Perl, T. M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect. 31, 13-24 (1995).
81. Tuazon, C. U., Perez, A., Kishaba, T. & Sheagren, J. N. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA 231, 1272 (1975).
82. Tuazon, C. U. & Sheagren, J. N. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J. Infect. Dis. 129, 725-727 (1974).
83. Yu, V. L. et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315, 91-96 (1986).
84. Weinstein, H. J. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N. Engl. J. Med. 260, 1303-1308 (1959).
85. Weinke, T., Schiller, R., Fehrenbach, F. J. & Pohle, H. D. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 11, 985-989 (1992).
86. Jevons, M. P., Coe, A. W. & Parker, M. T. Methicillin resistance in staphylococci. Lancet 1, 904-907 (1963).
87. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32, 470-485 (2004).
88. Tiemersma, E. W. et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Infect. Dis. 10, 1627-1634 (2004).
89. Crisostomo, M. I. et al. The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl Acad. Sci. USA 98, 9865-9870 (2001).
90. Enright, M. C. et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl Acad. Sci. USA 99, 7687-7692 (2002).
91. Udo, E. E., Pearman, J. W. & Grubb, W. B. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25, 97-108 (1993).
92. Fridkin, S. K. et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352, 1436-1444 (2005).
93. CDC. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morbid. Mortal. Wkly Rep. 48, 707-710 (1999).
94. Lina, G. et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128-1132 (1999).
95. Miller, L G. et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352, 1445-1453 (2005).
96. Daum, R. S. et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J. Infect. Dis. 186, 1344-1347 (2002).
97. Hiramatsu, K., Katayama, Y., Yuzawa, H. & Ito, T. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int. J. Med. Microbiol. 292, 67-74 (2002).
98. Ma, X. X. et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 46, 1147-1152 (2002).
99. Okuma, K. et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40, 4289-4294 (2002).
100. Calfee, D. P. et al. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect. Control Hosp. Epidemiol. 24, 422-426 (2003).
101. Saiman, L. et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 37, 1313-1319 (2003).
102. Archer, G. L. & Niemeyer, D. M. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 2, 343-347 (1994).
103. Baba, T. et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359, 1819-1827 (2002).
104. Robinson, D. A. et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365, 1256-1258 (2005).
105. CDC. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000. MMWR Morb. Mortal. Wkly Rep. 50, 919-922 (2001).
106. Charlebois, E. D. et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 39, 47-54 (2004).
107. Herold, B. C. et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279, 593-598 (1998).
108. Nguyen, D. M., Mascola, L. & Brancoft, E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg. Infect. Dis. 11, 526-532 (2005).
109. Zinderman, C. E. et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg. Infect. Dis. 10, 941-944 (2004).
110. Enne, V. I., Livermore, D. M., Stephens, P. & Hall, L. M. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357, 1325-1328 (2001).
111. Seppala, H. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N. Engl. J. Med. 337, 441-446 (1997).
112. Guillemot, D. et al. Low dosage and long treatment duration of β-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279, 365-370 (1998).
113. Schrag, S. J. et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. JAMA 286, 49-56 (2001).
114. Day, S., Ward, H., Ison, C., Bell, G. & Weber, J. Sexual networks: The integration of social and genetic data. Soc. Sci. Med. 47, 1981-1992 (1998).
115. Hoberman, A. et al. Penicillin susceptibility of pneumococcal isolates causing acute otitis media in children: Seasonal variation. Pediatr. Infect. Dis. J. 24, 115-120 (2005).
116. Karlowsky J. A. et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998-2002). Clin. Infect. Dis. 36, 963-970 (2003).
117. Mera, R. M., Miller, L. A., Daniels, J. J., Weil, J. G. & White, A. R. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn. Microbiol. Infect. Dis. 51, 195-200 (2005).
118. Temime, L., Guillemot, D. & Boelle, P. Y. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob. Agents Chemother. 48, 2206-2213 (2004).
119. Kaplan, S. L. et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113, 443-449 (2004).
120. Whitney, C. G. et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737-1746 (2003).
121. Jacobs, M. R. et al. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U. S. Surveillance study. Antimicrob. Agents Chemother. 43, 1901-1908 (1999).
122. Espinosa de los Monteros, L. E., Bustos, I. M., Flores, L. V. & Avila-Figueroa, C. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. Pediatr. Infect. Dis. J. 20, 807-809 (2001).
123. Holmstrom, L., Nyman, B., Rosengren, M., Wallander, S. & Ripa, T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. Scand. J. Infect. Dis. 22, 179-185 (1990).
124. Critchley I. A. et al. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Diagn. Microbiol. Infect. Dis. 42, 129-135 (2002).
125. Tanz, R. R. et al. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39, 1794-1801 (2004).
126. Martin, J. M., Green, M., Barbadora, K. A. & Wald, E. R. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346, 1200-1206 (2002).
127. Groom, A. V. et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286, 1201-1205 (2001).
128. Charlebois, E. D. et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin. Infect. Dis. 34, 425-433 (2002).
129. Hisata, K. et al. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J. Clin. Microbiol. 43, 3364-3372 (2005).
130. Pan, E. S. et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus - and their relation to community-associated disease activity. J. Infect. Dis. 192, 811-818 (2005).
131. Muder, R. R. et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann. Intern. Med. 114, 107-112 (1991).
132. Morris, J. G. Jr et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann. Intern. Med. 123, 250-259 (1995).
133. Bates, J., Jordens, J. Z. & Griffiths, D. T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34, 507-514 (1994).
134. Bhuiyan, B. U. et al. Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: Emergence of high-level resistance to ciprofloxacin. J. Clin. Microbiol. 37, 1130-1136 (1999).
135. Fornasini, M., Reves, R. R., Murray, B. E., Morrow, A. L. & Pickering, L. K. Trimethoprim-resistant Escherichia coli in households of children attending day care centers. J. Infect. Dis. 166, 326-30 (1992).
136. Smith, K. E. et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N. Engl. J. Med. 340, 1525-1532 (1999).